Next 10 |
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to appro...
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digi...
Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has been invited to present at the Lake Street’s 5th Annual Best Id...
Pivotal trial of BT-001 in type 2 diabetes expected to be fully enrolled in Q4 2021, with primary endpoint readout in Q1 2022; de novo submission to FDA requesting marketing authorization planned following completion of trial Clinical development of BT-002 and BT-003 in hypert...
Open-label, real-world study will evaluate BT-001’s cognitive behavioral therapy approach to change behaviors at the root cause of type 2 diabetes Study to evaluate the durability of treatment effect and healthcare utilization changes associated with BT-001 in Catalyst&...
Mountain Crest Acquisition Corp. III (MCAEU), the third SPAC from the team that bought Playboy parent PLBY Group (PLBY) public in what’s been a wildly successful deal so far, inched up on its first trading day Tuesday following an IPO.Mountain Crest’s units were trading at $10.0...
The SPAC team that took Playboy Group (PLBY) public in what’s turned out to be a wildly successful deal is launching a $50M IPO for Mountain Crest Acquisition Corp. III (MCAEU), its third special purpose acquisition company.Dr. Suying Liu, whose Mountain Crest Acquisition Corp. I took ...
Open-label, non-randomized, controlled study will span one year and evaluate BT-001’s cognitive behavioral therapy approach to change behaviors at root cause of type 2 diabetes Study to evaluate the durability of treatment effect and total cost of care impact of BT-001 ...
Genworth Financial finally terminates its deal with China Oceanwide. Tribune Publishing Company receives a revised, non-binding proposal from Newslight. Leaf Group to be acquired by Graham Holdings Company. For further details see: Merger Arbitrage Mondays - Leaf Group A...
Transaction values Better Therapeutics at a pro forma fully diluted enterprise value of approximately $187 million with existing Better Therapeutics shareholders rolling over 100% of their equity into equity of the combined company Transaction expected to provide up to $113 mi...
News, Short Squeeze, Breakout and More Instantly...
Mountain Crest Acquisition Corp. II Company Name:
MCAD Stock Symbol:
NASDAQ Market:
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to appro...
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digi...
Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has been invited to present at the Lake Street’s 5th Annual Best Id...